RT Book, Section
A1 Gruenberg, Katherine
A1 Guglielmo, B. Joseph
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1184154409
T1 Antiviral Chemotherapy
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1184154409
RD 2024/04/19
AB KEY  CLINICAL  UPDATE  IN  ANTIVIRAL  CHEMOTHERAPYRemdesivir  is  approved  for  the  treatment  of  SARS-CoV-2  in  hospitalized  patients.In  a  multinational,  randomized  trial,  hospitalized  patients  infected  with  SARS-CoV-2  who  received  remdesivir  showed  a  significant  reduction  in  the  time  to  recovery  compared  to  those  who  received  placebo;  those  requiring  supplemental  oxygen  benefited  the  most  from  remdesivir  treatment.